Immediate Impact
2 from Science/Nature 61 standout
Citing Papers
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Works of Emi Kamiyama being referenced
Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors
2021
Phase 1 study of new formulation of patritumab (U3-1287) Process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non-small cell lung cancer
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Emi Kamiyama | 289 | 45 | 50 | 109 | 84 | 22 | 467 | |
| Daria Stypinski | 164 | 39 | 97 | 80 | 78 | 29 | 548 | |
| Maria M. Posada | 260 | 46 | 14 | 116 | 113 | 21 | 493 | |
| B Booth | 170 | 35 | 46 | 79 | 86 | 17 | 520 | |
| Kenji Tabata | 210 | 26 | 16 | 67 | 112 | 29 | 551 | |
| Eric Y. Zhang | 185 | 6 | 43 | 76 | 125 | 11 | 412 | |
| Lucy Sasongko | 333 | 9 | 43 | 285 | 62 | 21 | 524 | |
| Ryosei Kawai | 108 | 16 | 29 | 51 | 99 | 16 | 476 | |
| Sumihisa Kimura | 221 | 14 | 53 | 35 | 114 | 13 | 525 | |
| Sarinj Fattah | 167 | 23 | 8 | 75 | 148 | 16 | 470 | |
| Manford C. Castle | 185 | 53 | 14 | 44 | 142 | 22 | 465 |
All Works
Loading papers...